Hexima (ASX:HXL) Machinery, Furniture, Equipment : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Hexima Machinery, Furniture, Equipment?

Hexima's Machinery, Furniture, Equipment for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Hexima's annual Machinery, Furniture, Equipment increased from Jun. 2021 (A$0.13 Mil) to Jun. 2022 (A$1.07 Mil) but then declined from Jun. 2022 (A$1.07 Mil) to Jun. 2023 (A$0.00 Mil).

Hexima Machinery, Furniture, Equipment Historical Data

The historical data trend for Hexima's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima Machinery, Furniture, Equipment Chart

Hexima Annual Data

Trend

Jun08

Jun09

Jun10

Jun20

Jun21

Jun22

Jun23

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

3.20

1.28

0.13

1.07

Hexima Semi-Annual Data
	Dec06	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Machinery, Furniture, Equipment	Get a 7-Day Free Trial										0.12	1.07	-	-	-

Hexima Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Hexima (ASX:HXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072

Website

https://www.hexima.com.au

Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.